PIM
MDCO

Partner Investment Management’s Medicines Co MDCO Stock Holding History

Partner Investment Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-21,300
Closed -$810K – 101
2017
Q2 		$810K Buy
21,300
+14,700
+223% +$655K 1.09% 36
2017
Q1 		$323K Buy
+6,600
New +$301K 0.39% 71
2016
Q4 		– Sell
-6,100
Closed -$230K – 118
2016
Q3 		$230K Buy
+6,100
New +$230K 0.34% 70

Other funds holding MDCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Partner Investment Management's MDCO Position: Q4 2018 in Review

Partner Investment Management sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 34,960 shares — an estimated $1.05M sold.

Partner Investment Management first reported a position in MDCO in Q3 2013 and held it in 19 quarters. The position peaked at $4.13M in Q3 2013. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • Partner Investment Management reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • Partner Investment Management sold 34,960 Medicines Co shares in Q4 2018, an estimated $1.05M.
  • Partner Investment Management first reported a position in Medicines Co in Q3 2013 and held it in 19 quarters.
  • Partner Investment Management's Medicines Co position peaked at $4.13M in Q3 2013.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on Partner Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.